ATE248590T1 - Monolithsysteme enthaltend mindestens einer wirkstoff, bestehend aus drei schichten mit unterschiedlichen freisetzungmechanismus - Google Patents

Monolithsysteme enthaltend mindestens einer wirkstoff, bestehend aus drei schichten mit unterschiedlichen freisetzungmechanismus

Info

Publication number
ATE248590T1
ATE248590T1 AT98950099T AT98950099T ATE248590T1 AT E248590 T1 ATE248590 T1 AT E248590T1 AT 98950099 T AT98950099 T AT 98950099T AT 98950099 T AT98950099 T AT 98950099T AT E248590 T1 ATE248590 T1 AT E248590T1
Authority
AT
Austria
Prior art keywords
layers
active ingredient
systems containing
release mechanisms
different release
Prior art date
Application number
AT98950099T
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Daniela Acerbi
Rossela Musa
Ruggero Bettini
Giovanni Caponetti
Pier Luigi Catellani
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE248590T1 publication Critical patent/ATE248590T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT98950099T 1997-10-03 1998-10-01 Monolithsysteme enthaltend mindestens einer wirkstoff, bestehend aus drei schichten mit unterschiedlichen freisetzungmechanismus ATE248590T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002254A IT1295271B1 (it) 1997-10-03 1997-10-03 Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
PCT/EP1998/006228 WO1999017745A1 (en) 1997-10-03 1998-10-01 Monolithic system containing one or more drugs, consisting of three layers with different release mechanisms

Publications (1)

Publication Number Publication Date
ATE248590T1 true ATE248590T1 (de) 2003-09-15

Family

ID=11377984

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98950099T ATE248590T1 (de) 1997-10-03 1998-10-01 Monolithsysteme enthaltend mindestens einer wirkstoff, bestehend aus drei schichten mit unterschiedlichen freisetzungmechanismus

Country Status (14)

Country Link
EP (1) EP1019029B1 (de)
AR (1) AR043070A1 (de)
AT (1) ATE248590T1 (de)
AU (1) AU9629198A (de)
BR (1) BR9815248A (de)
CZ (1) CZ298851B6 (de)
DE (1) DE69817848T2 (de)
ES (1) ES2205558T3 (de)
HU (1) HU225692B1 (de)
IT (1) IT1295271B1 (de)
NO (1) NO20001709L (de)
SK (1) SK284552B6 (de)
WO (1) WO1999017745A1 (de)
ZA (1) ZA989010B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041646A2 (en) 2001-11-13 2003-05-22 Teva Pharmaceutical Industries, Ltd. L-dopa ethyl ester salts and uses thereof
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
CA2613631A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Improved dosage forms for movement disorder treatment
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
CN102202656A (zh) 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
WO2011124953A2 (en) * 2010-04-07 2011-10-13 Lupin Limited Controlled release pharmaceutical compositions of tapentadol
EP2508174A1 (de) 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmazeutische Zusammensetzung
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
ITMI20121263A1 (it) 2012-07-19 2014-01-20 Recordati Ind Chimica E Farma Ceutica S P A Forma farmaceutica multistrato
WO2014197744A1 (en) 2013-06-05 2014-12-11 Synchroneuron, Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
CN105658211A (zh) 2013-10-07 2016-06-08 怡百克制药公司 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
US9808478B2 (en) * 2015-04-17 2017-11-07 Steven Loyd Control release of fat soluble antioxidants from an oral formulation and method
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen
KR20230124622A (ko) 2020-12-22 2023-08-25 암닐 파마슈티컬스 엘엘씨 레보도파 투여 요법
CN117599009A (zh) * 2023-11-10 2024-02-27 长沙晶易医药科技股份有限公司 一种卡左双多巴三层片及其制备方法
CN118831063A (zh) * 2024-07-18 2024-10-25 泰州越洋医药开发有限公司 一种三层片制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili

Also Published As

Publication number Publication date
CZ298851B6 (cs) 2008-02-27
IT1295271B1 (it) 1999-05-04
AR043070A1 (es) 2005-07-20
HUP0004015A2 (hu) 2001-08-28
WO1999017745A1 (en) 1999-04-15
SK4822000A3 (en) 2000-09-12
ZA989010B (en) 1999-04-12
DE69817848D1 (de) 2003-10-09
NO20001709D0 (no) 2000-04-03
CZ20001200A3 (cs) 2000-09-13
BR9815248A (pt) 2000-11-21
AU9629198A (en) 1999-04-27
NO20001709L (no) 2000-06-05
EP1019029A1 (de) 2000-07-19
HUP0004015A3 (en) 2006-06-28
DE69817848T2 (de) 2005-04-07
SK284552B6 (sk) 2005-06-02
ITMI972254A1 (it) 1999-04-03
ES2205558T3 (es) 2004-05-01
EP1019029B1 (de) 2003-09-03
HU225692B1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
ATE248590T1 (de) Monolithsysteme enthaltend mindestens einer wirkstoff, bestehend aus drei schichten mit unterschiedlichen freisetzungmechanismus
AR017897A1 (es) Un comprimido de capas multiples para la liberacion instantanea y prolongada de sustancias activas que contiene al menos dos capas superpuestas, y un procedimiento para su preparacion
DK0643589T3 (da) Spærrelagsisolationsanlæg
FI941378L (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
DE69807642D1 (de) Tampon mit einer perforierten, äusseren folienumhüllung
DE69814439D1 (de) Modulare betätigungsvorrichtung sowie bremssattel mit einer solchen betätigungsvorrichtung
FI930657A7 (fi) Menetelmä pidennetyn aktiiviaineluovutuksen omaavien annosmuotojen valmistamiseksi
FI962618A0 (fi) Perkutaanisesti absorboituva valmiste
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
DE60037862D1 (de) Funkkommunikationssystem mit wahlfreien zugriffsanforderungen bestehend aus einer mehrzahl von zugriffspaketen
DE68920697D1 (de) Insektenvertreibungsmittel mit gesteuerter Freisetzung.
BR9201305A (pt) Composto,composicao inseticida,processos para controlar insetos e para preparar o composto
DE69714832D1 (de) Absorbierende Artikel mit verbesserter Trennschicht
DE59404834D1 (de) Stellantrieb mit Federrücklauf
DE19983755T1 (de) Absorbierender Artikel mit einer gelochten Zwischenschicht
MX9203070A (es) Compuestos con propiedades inhibidoras de la renina, procedimiento para su preparacion y su empleo.
FI954497A7 (fi) Aktiivista ainetta sisältävä laastari estradiolin vapauttamiseksi ihoo n
BR8900933A (pt) Pelicula composta multipla,pelicula composta multipla de camadas multiplas e pelicula composta de camadas multiplas
BR9404147A (pt) Composto dihalopropeno, inseticida/acaricida, método para controlar pragas de insetos nocivos, uso do dito composto, processo para produzir o mesmo e composto intermediário
DE59502831D1 (de) Quantenschichtstruktur
EP0995424A3 (de) Deodoriende Kombinationen von Antiadhäsiva (Ceramide und Sphingosine und Derivate) und Mikrobiziden
BR9806501B1 (pt) composto purificado, bem como composição pesticida e método para controlar pestes compreendendo o mesmo e uso do mesmo.
EP0570821A3 (de) Aktives Freilaufelement.
DE69623177D1 (de) Bauelement mit einer Schicht aus beta-C3N4
FI933808A0 (fi) Insekticidiskt aktiva peptider

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1019029

Country of ref document: EP

REN Ceased due to non-payment of the annual fee